Cupid Ltd
Established in 1993, CUPID Limited is India's premier manufacturer of male and female condoms, personal lubricant, and IVD kits.[1]
- Market Cap ₹ 2,199 Cr.
- Current Price ₹ 81.9
- High / Low ₹ 142 / 43.0
- Stock P/E 43.2
- Book Value ₹ 11.9
- Dividend Yield 0.00 %
- ROCE 21.7 %
- ROE 16.5 %
- Face Value ₹ 1.00
Pros
- Company is almost debt free.
- Company is expected to give good quarter
- Promoter holding has increased by 0.82% over last quarter.
Cons
- Promoters have pledged 31.0% of their holding.
- Debtor days have increased from 81.7 to 102 days.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: Miscellaneous Industry: Miscellaneous
Part of BSE Allcap BSE Fast Moving Consumer Goods BSE SmallCap
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | TTM | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
28 | 20 | 44 | 61 | 84 | 81 | 85 | 160 | 143 | 133 | 159 | 171 | 197 | |
25 | 17 | 32 | 36 | 50 | 53 | 65 | 108 | 107 | 109 | 118 | 121 | 124 | |
Operating Profit | 3 | 2 | 13 | 25 | 34 | 27 | 21 | 52 | 36 | 23 | 41 | 50 | 74 |
OPM % | 10% | 10% | 29% | 41% | 41% | 34% | 24% | 33% | 25% | 17% | 26% | 29% | 37% |
0 | 0 | 1 | 2 | 1 | 1 | 2 | 3 | 5 | 4 | 5 | 7 | 1 | |
Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 0 | 1 | 2 | 2 |
Depreciation | 1 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 3 | 3 | 3 | 3 | 3 |
Profit before tax | 1 | 0 | 11 | 25 | 32 | 26 | 21 | 53 | 38 | 25 | 42 | 53 | 69 |
Tax % | 37% | 60% | 33% | 36% | 37% | 34% | 27% | 24% | 24% | 30% | 25% | 24% | |
1 | 0 | 8 | 16 | 21 | 17 | 15 | 40 | 29 | 17 | 32 | 40 | 51 | |
EPS in Rs | 0.03 | 0.00 | 0.29 | 0.60 | 0.77 | 0.64 | 0.57 | 1.49 | 1.09 | 0.65 | 1.18 | 1.49 | 1.90 |
Dividend Payout % | 0% | 0% | 22% | 21% | 22% | 29% | 35% | 15% | 21% | 35% | 21% | 0% |
Compounded Sales Growth | |
---|---|
10 Years: | 24% |
5 Years: | 15% |
3 Years: | 6% |
TTM: | 26% |
Compounded Profit Growth | |
---|---|
10 Years: | 86% |
5 Years: | 21% |
3 Years: | 11% |
TTM: | 98% |
Stock Price CAGR | |
---|---|
10 Years: | 46% |
5 Years: | 52% |
3 Years: | 94% |
1 Year: | 85% |
Return on Equity | |
---|---|
10 Years: | 24% |
5 Years: | 21% |
3 Years: | 16% |
Last Year: | 16% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Sep 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 11 | 11 | 11 | 11 | 11 | 11 | 13 | 13 | 13 | 13 | 13 | 13 | 27 |
Reserves | 7 | 7 | 13 | 25 | 43 | 55 | 63 | 90 | 118 | 129 | 154 | 288 | 294 |
2 | 3 | 2 | 1 | 0 | 2 | 2 | 31 | 0 | 9 | 6 | 12 | 16 | |
4 | 5 | 8 | 14 | 9 | 10 | 15 | 30 | 22 | 23 | 16 | 7 | 22 | |
Total Liabilities | 25 | 27 | 35 | 51 | 63 | 78 | 93 | 165 | 152 | 174 | 189 | 320 | 359 |
17 | 16 | 16 | 16 | 16 | 16 | 21 | 26 | 29 | 31 | 36 | 58 | 66 | |
CWIP | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3 | 1 | 6 | 0 | 0 | 0 |
Investments | 0 | 0 | 0 | 0 | 5 | 18 | 22 | 21 | 48 | 54 | 69 | 135 | 131 |
7 | 10 | 19 | 35 | 42 | 44 | 50 | 114 | 74 | 84 | 83 | 126 | 161 | |
Total Assets | 25 | 27 | 35 | 51 | 63 | 78 | 93 | 165 | 152 | 174 | 189 | 320 | 359 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
2 | -0 | 7 | 13 | 20 | 3 | 18 | 19 | 42 | 10 | 33 | 8 | |
-0 | -0 | -1 | -1 | -5 | -9 | -14 | -37 | -9 | -13 | -22 | -80 | |
-1 | 1 | -3 | -6 | -4 | -3 | -5 | 16 | -33 | 3 | -11 | 99 | |
Net Cash Flow | 0 | 0 | 3 | 6 | 11 | -9 | -0 | -2 | 0 | -1 | -0 | 27 |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 16 | 59 | 67 | 79 | 59 | 100 | 97 | 95 | 65 | 84 | 59 | 102 |
Inventory Days | 63 | 165 | 155 | 60 | 133 | 259 | 168 | 437 | 230 | 197 | 229 | 184 |
Days Payable | 32 | 81 | 84 | 27 | 80 | 162 | 135 | 579 | 168 | 134 | 105 | 1 |
Cash Conversion Cycle | 47 | 144 | 139 | 112 | 112 | 198 | 130 | -46 | 127 | 147 | 183 | 286 |
Working Capital Days | 49 | 120 | 76 | 82 | 67 | 140 | 118 | 111 | 87 | 111 | 91 | 149 |
ROCE % | 9% | 3% | 48% | 79% | 72% | 43% | 29% | 50% | 28% | 17% | 26% | 22% |
Documents
Announcements
- Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 9 Dec
- Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 9 Dec
- Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 9 Dec
-
Disclosure Under Regulation 29(2) Of SEBI (SAST) Regulations,
2011.
7 Dec - Disclosure received from promoter under SEBI regulations.
- Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 6 Dec
Annual reports
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
-
Financial Year 2010
from bse
Concalls
-
Aug 2024TranscriptNotesPPT
-
Apr 2024TranscriptNotesPPT
-
Jan 2024Transcript PPT
-
Nov 2023TranscriptPPTREC
-
Aug 2023TranscriptPPT
-
Jun 2023Transcript PPT
-
Feb 2023TranscriptPPT
-
Nov 2022Transcript PPT
-
Aug 2022TranscriptPPT
-
Jun 2022TranscriptPPT
-
Feb 2022TranscriptPPT
-
Nov 2021Transcript PPT
-
Aug 2021TranscriptPPT
-
Jun 2021TranscriptPPT
-
Feb 2021TranscriptPPT
-
Nov 2020TranscriptPPT
-
Sep 2020TranscriptPPT
-
Jan 2020TranscriptPPT
-
Nov 2019TranscriptPPT
-
Jul 2019TranscriptPPT
-
Jun 2019TranscriptPPT
-
Feb 2019TranscriptPPT
-
Nov 2018TranscriptPPT
-
Aug 2018TranscriptPPT
-
Feb 2018TranscriptNotesPPT
-
Nov 2017TranscriptPPT
-
Jul 2017TranscriptPPT
-
May 2017TranscriptPPT
-
Nov 2016TranscriptPPT
-
Jul 2016TranscriptPPT
-
May 2016Transcript PPT
Products Offered[1]
The Co. manufactures male condoms, female condoms, water-based lubricant jelly, IVD products such as Pregnancy Test Kits, Covid 19 Antigen Test Kit, HIV Test Kit, Dengue test kits, Malaria antigen test kits, etc.